Galderma SA - Mirvaso 3.3mg/g, Gel Swissmedic Registration 65180 Sequence 01 Product name Mirvaso 3.3mg/g Description Gel ATC-Classification D11AX21 ATC-Description Brimonidine Introduction of Sequence 21.11.2014
Composition Gel: brimonidini tartras 5 mg corresp. brimonidinum 3.3 mg, carbomerum, E 218 1 mg, phenoxyethanolum, glycerolum, E 171, propylenglycolum 55 mg, natrii hydroxidum ad pH, aqua purificata, ad gelatum pro 1 g. Packungsbestandteile Galenic Form Gel Active Agent Dose additional_information Brimonidine Tartrate 5 mg correspond Brimonidine 3.3 mg Gel
BAG: Active Agent Dose Brimonidine 3.3 mg
Inactive agents Dose additional_information Ad Gelatum 1 g Aqua Purificata Carbomer E 171 color. E 218 1 mg conserv. Glycerol Natrii Hydroxidum ad Ph Phenoxyethanol Propylenglycol 55 mg
Package number Package Size EFP CP Category SL Out of trade (MedRef) 002 30 g 37.44 57.15 B SL No